ArticleClinical hematology international2025
Real-world outcomes in patients with relapsed and refractory multiple myeloma with prior proteasome inhibitor and lenalidomide exposure: A single-center study in Sweden.
Vincent Luong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.